Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral neuronal voltage-gated sodium channels (VGSCs), primarily comprising the NaV1.7, NaV1.8, and NaV1.9 subtypes, are essential for the initiation and propagation of action potentials in peripheral sensory neurons, particularly nociceptors (Dib-Hajj et al., 2013, Nat Rev Neurosci). These channels respond to membrane depolarization by opening a pore that allows sodium ions to enter the cell, a process critical for transmitting pain signals from the periphery to the central nervous system (Bennett et al., 2019, Lancet Neurol). NaV1.7 (SCN9A) acts as a threshold setter, NaV1.8 (SCN10A) provides the bulk of the inward current during the action potential upstroke, and NaV1.9 (SCN11A) regulates resting membrane potential and excitability (Wood et al., 2004, J Pain). Mutations in the genes encoding these channels are linked to diverse pain disorders, such as inherited erythromelalgia and congenital insensitivity to pain, making them high-value targets for non-opioid analgesics (Habibi et al., 2020, Front Pharmacol). Pharmacological modulation typically involves small-molecule inhibitors, such as the selective NaV1.8 inhibitor suzetrigine (VX-548), which aim to block pain signaling while avoiding the cardiac and central nervous system side effects associated with non-selective sodium channel blockers (Vertex Pharmaceuticals, 2024). These channels represent a critical interface between external stimuli and the electrical signaling of the nervous system, and their selective inhibition remains a major focus of drug development for chronic and acute pain management.
Inhibition of sodium ion influx through the alpha-subunit pore or stabilization of the inactivated state of the channel to prevent action potential propagation in peripheral sensory neurons.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral neuronal voltage-gated sodium channel (Peripheral NaV) (Peripheral NaV).